Home/Filings/4/0001213900-22-058482
4//SEC Filing

Gold Lawrence Marshall 4

Accession 0001213900-22-058482

CIK 0001690080other

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 6:14 PM ET

Size

5.1 KB

Accession

0001213900-22-058482

Insider Transaction Report

Form 4
Period: 2022-07-27
Transactions
  • Award

    Common Stock

    2022-07-27+13,06835,096 total
Footnotes (1)
  • [F1]Issued in consideration for serving on the Board of Directors, as a Member of the Audit and Compensation Committee of the Board of Directors, and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended June 30, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.

Documents

1 file

Issuer

180 Life Sciences Corp.

CIK 0001690080

Entity typeother

Related Parties

1
  • filerCIK 0001355868

Filing Metadata

Form type
4
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 6:14 PM ET
Size
5.1 KB